Cerus Corporation
Clinical trials sponsored by Cerus Corporation, explained in plain language.
-
New blood treatment aims to block zika during transfusions
Disease control OngoingThis study tests whether treating red blood cells with the INTERCEPT Blood System can safely reduce the risk of Zika virus transmission during transfusions. About 692 patients who need blood transfusions will receive either treated or standard red blood cells. The main goals are …
Phase: PHASE3 • Sponsor: Cerus Corporation • Aim: Disease control
Last updated Apr 26, 2026 19:35 UTC
-
Sickle cell blood study pulled before it began
Knowledge-focused TerminatedThis study was designed to track how long specially treated red blood cells survive in people with sickle cell disease who receive regular blood exchanges. It planned to enroll adults with sickle cell disease who had been on exchange therapy for at least three months. However, th…
Phase: PHASE2 • Sponsor: Cerus Corporation • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC